These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 5271349)
41. [Hyperthrombocytosis of the blood caused by late platelet-producing reticulomyelosis during radiotherapy of myeloid leukemia]. CROIZAT P; GUICHARD A; MOREL P Lyon Med; 1957 May; 89(20):467-76. PubMed ID: 13450542 [No Abstract] [Full Text] [Related]
42. Clinicopathological conference: Mesenteric venous thrombosis, splenomegaly, and thrombocytosis. Va Med Mon (1918); 1970 Jun; 97(6):369-78. PubMed ID: 5293582 [No Abstract] [Full Text] [Related]
43. [Heterogeneity of granulocyte chemiluminescence in chronic myeloid leukemia]. Ohnishi M; Shibata A; Shinada S Rinsho Ketsueki; 1984 Sep; 25(9):1402-7. PubMed ID: 6596450 [No Abstract] [Full Text] [Related]
44. Megakaryoblastic transformation of primary thrombocythemia. Reiffers J; Dachary D; David B; Bernard P; Marit G; Boisseau M; Broustet A Acta Haematol; 1985; 73(4):228-31. PubMed ID: 3933245 [TBL] [Abstract][Full Text] [Related]
45. [Treatment of chronic myeloid leukemia with dibromomannitol]. Clément F; Saillen R Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364 [No Abstract] [Full Text] [Related]
47. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders. Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512 [TBL] [Abstract][Full Text] [Related]
48. [MAJOR HYPERTHROMBOCYTOSIS (UP TO 2,250,000) IN THE COURSE OF MYELOID LEUKEMIA OBSERVED 6 YEARS AFTER SPLENECTOMY]. PLAUCHU M; LOIRE R; BANSILLON V; FEDDY Lyon Med; 1963 Sep; 210():461-75. PubMed ID: 14087790 [No Abstract] [Full Text] [Related]
49. Medical Grand Rounds--chronic granulocytic leukemia with thrombocytosis; the hypercoagulability states. Kossmann CE; Hubbard WS; Chesney CM J Tenn Med Assoc; 1981 Oct; 74(10):742-3, 745. PubMed ID: 6947124 [No Abstract] [Full Text] [Related]
50. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders. Tangün Y Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903 [No Abstract] [Full Text] [Related]
51. [Chromosome abnormalities and chronic myeloid leukemia: Sherbrooke's experience]. Rochon M; Vaillancourt L; Boucher A; Massé S Union Med Can; 1983 Jan; 112(1):52-4. PubMed ID: 6573054 [No Abstract] [Full Text] [Related]
57. [Chronic myelocytic leukemia: apparent "recovery" for over nine years, following therapeutic medullary hypoplasia. A clinical and cytogenetic study]. Mauruce PA; Ferrier S; Alberto P; Freund M Schweiz Med Wochenschr; 1971 Dec; 101(49):1781-2. PubMed ID: 5291101 [No Abstract] [Full Text] [Related]
58. [Paraproteinemia and its possible prognostic significance in chronic myelosis]. Tishchenko LM; Guseva SA; Sarnitskiĭ IP Vrach Delo; 1984 Jul; (7):105-7. PubMed ID: 6591628 [No Abstract] [Full Text] [Related]
59. [Unusual and atypical forms of chronic myeloleukemia]. Lebedev VN; Moiseenko MI Ter Arkh; 1974; 46(1):93-6. PubMed ID: 4532872 [No Abstract] [Full Text] [Related]
60. Platelet kinetics in splenomegaly. Dillon DE; Watt JE; Jones AE; Conrad ME Med Ann Dist Columbia; 1970 Jul; 39(7):365-8. PubMed ID: 5270074 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]